Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > ASH 2024: Roundup of news from last day of hematology meeting
Health and Wellness

ASH 2024: Roundup of news from last day of hematology meeting

Last updated: December 10, 2024 7:35 pm
Share
ASH 2024: Roundup of news from last day of hematology meeting
SHARE

The ASH 2024 conference has been buzzing with exciting developments in the field of hematology. As the conference comes to a close in San Diego, attendees are already looking forward to next year’s event in Orlando. Here is a recap of some of the most notable news from the conference:

The feud between Arcellx and Legend Biotech over their anti-BCMA CAR-T therapies for multiple myeloma has been making headlines. Arcellx received a special waiver to issue an early press release highlighting the lack of delayed neurotoxicity associated with its experimental treatment, anito-cel, in an attempt to disrupt Legend’s investor meeting. Legend, on the other hand, remains confident in its own therapy, Carvykti, which has already established itself as a standard-of-care treatment for multiple myeloma.

In a significant development for mantle cell lymphoma patients, a randomized trial has shown that autologous stem cell transplants may not be necessary for patients in deep remission after initial therapy. The results of the trial have reinforced the growing trend among clinicians to move away from transplants for these patients, as newer targeted and immune therapies have improved outcomes significantly.

Amgen’s Blincyto has shown promising results in improving disease-free survival in pediatric patients with acute lymphoblastic leukemia. The bispecific T-cell engager, when added to standard chemotherapy, significantly increased three-year disease-free survival rates in children with B-cell ALL. While the treatment may come with some risks, particularly infections, it has shown to be beneficial for high-risk populations.

For patients with chronic lymphocytic leukemia who have failed other treatments, Abbvie’s Epkinly, a bispecific T-cell engager, may offer a chance for complete remission. In a phase 1/2 trial, a significant number of patients responded to the drug, with some achieving a complete response. This is a promising development for CLL patients who have limited treatment options after relapse.

See also  Deal of the Day: Save 20% at Beyond Yoga

Overall, the ASH 2024 conference has showcased the latest advancements in hematology research and treatment options. From cutting-edge CAR-T therapies to promising new drug combinations, the future looks bright for patients with hematologic disorders. Stay tuned for more updates and breakthroughs in hematology as we look forward to next year’s conference in Orlando.

TAGGED:AshDayhematologyMeetingNewsRoundup
Share This Article
Twitter Email Copy Link Print
Previous Article Most picked teams in Honkai Star Rail 2.6 Memory of Chaos Most picked teams in Honkai Star Rail 2.6 Memory of Chaos
Next Article Chronic Spontaneous Urticaria: One Women’s Diagnosis Journey Chronic Spontaneous Urticaria: One Women’s Diagnosis Journey
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Donald Trump defends national security adviser over chat breach

Unlock the White House Watch newsletter for free Are you curious about what the 2024…

March 25, 2025

Veterans are divided over the Army’s big parade being held on Trump’s birthday

Military Veterans Divided Over Army's 250th Anniversary Parade As the U.S. Army prepares to celebrate…

June 11, 2025

This LA Vintage Store Is Taking on Europe’s Best—Just Ask Hailey and Kendall

Paris stands as a top destination for vintage shopping, offering endless treasures for those hunting…

October 5, 2025

Israel’s Netanyahu Vows To ‘Eliminate’ Hamas Amid Ceasefire Deal

Hamas released 3 hostages in the 5th round of ceasefire deal. Jerusalem: Israel's Prime Minister…

February 8, 2025

Scientists Reveal a Crucial Surprise About The Mega-Shark : ScienceAlert

A recent study led by paleontologist Kenshu Shimada of DePaul University has provided new insights…

March 10, 2025

You Might Also Like

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed
Health and Wellness

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed

October 10, 2025
WGA Urges CBS News Staffers to Not Respond to Bari Weiss Info-Seeking Memo Until Company Provides Details on Purpose of Her Email (EXCLUSIVE)
Entertainment

WGA Urges CBS News Staffers to Not Respond to Bari Weiss Info-Seeking Memo Until Company Provides Details on Purpose of Her Email (EXCLUSIVE)

October 10, 2025
General Pulaski Memorial Day, 2025
The White House

General Pulaski Memorial Day, 2025

October 10, 2025
Trump raises China tariffs by 100% and threatens to scrap Xi meeting over export rules
World News

Trump raises China tariffs by 100% and threatens to scrap Xi meeting over export rules

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?